PF3D7_0920500

PF3D7_0920500 encodes a functional class I ADP-ribosylation factor GTPase of Plasmodium falciparum (PfARF1) that governs early secretory trafficking in the intraerythrocytic parasite (PMID:8954160, PMID:33604307). The recombinant protein purifies with stoichiometrically bound GDP, binds GTP with first-order kinetics, and stimulates cholera-toxin-catalyzed ADP-ribosyltransferase activity, defining it biochemically as a class I ARF (PMID:8954160); its GDP-bound crystal structure at 2.5 Å resolution shows the fold is conserved relative to mammalian class I ARF1 (PMID:21045287). N-myristoylated PfARF1 localizes to the parasite Golgi and, in early erythrocytic stages, to an ER subdomain adjacent to and associated with PfRab5b, distinct from the PfRab1b compartment (PMID:25909331, PMID:33604307). A dominant-negative (inactive) PfARF1 mutant blocks ER exit of the PEXEL-negative cargo PfAK2 to the parasitophorous vacuole membrane and reduces export of the PEXEL-positive protein Rifin, establishing PfARF1 as a regulator of ER exit for both cargo classes (PMID:33604307). PfARF1 additionally activates the parasite's unique bifunctional PIP5K in vitro, linking it to phosphoinositide signalling (PMID:19171150). Its mRNA peaks during nuclear division late in the asexual blood-stage cycle (PMID:8954160). Beyond these findings, the guanine-nucleotide exchange factors, GAPs, and full effector network of PfARF1 have not been characterized in the available corpus.

1. 1996 High

   Establishing that the parasite gene product is a bona fide functional GTPase was the necessary first step to treating it as an ARF rather than an annotated ORF.

   Evidence Recombinant expression in E. coli with GTP-binding kinetics and cholera-toxin ADP-ribosyltransferase stimulation assays

   PMID:8954160

   Open questions at the time

   • In vitro assays do not identify the cellular GEF/GAP that cycles PfARF1 in the parasite
   • No cargo or effector identified at this stage
2. 1996 Medium

   Defining when PfARF1 is expressed situated the GTPase within the asexual developmental program, hinting at peak demand for secretory trafficking late in the cycle.

   Evidence Northern blot of 1.8 kb transcript across intraerythrocytic stages

   PMID:8954160

   Open questions at the time

   • mRNA timing not linked to protein abundance or to a functional trafficking consequence
3. 2009 Medium

   Connecting PfARF1 to a parasite lipid kinase addressed whether the GTPase couples membrane trafficking to phosphoinositide signalling.

   Evidence In vitro kinase activation assay with recombinant PfARF1 and recombinant bifunctional PfPIP5K

   PMID:19171150

   Open questions at the time

   • Activation shown only in vitro; not validated in parasites
   • The membrane pool and localization of PIP5K activation relative to PfARF1 not established
4. 2010 High

   Solving the GDP-bound structure provided the molecular framework showing PfARF1 conserves the mammalian class I ARF architecture.

   Evidence X-ray crystallography at 2.5 Å with structural comparison to mammalian ARF1

   PMID:21045287

   Open questions at the time

   • GTP-bound/active conformation not captured
   • No structure of PfARF1 bound to an effector or GEF
5. 2015 Medium

   Localizing N-myristoylated PfARF1 to the Golgi and dissecting its N-terminus via chimeras clarified how membrane targeting motifs contribute to cargo trafficking.

   Evidence GFP-tagging, fluorescence co-localisation with a Golgi marker, and chimeric fusion constructs combining PfARF1 and PfAK2 motifs

   PMID:25909331

   Open questions at the time

   • Chimera reached the plasma membrane but not the parasitophorous vacuole, so the full PfAK2 translocation determinants remain undefined
   • Golgi localization based on single-lab imaging
6. 2021 High

   Placing PfARF1 in a PfRab5b-associated ER subdomain and showing a dominant-negative mutant blocks cargo export defined its role as a regulator of ER exit for both PEXEL-negative and PEXEL-positive proteins.

   Evidence Co-IP/mass spectrometry, super-resolution immunofluorescence, and active/inactive GTPase mutant expression in P. falciparum

   PMID:33604307

   Open questions at the time

   • Whether PfARF1 and PfRab5b act as a direct complex or in parallel steps not resolved
   • Mechanism by which the same GTPase handles distinct PEXEL-positive and PEXEL-negative cargo not defined

• The regulatory machinery (GEFs, GAPs) and the complete effector/cargo repertoire that couple PfARF1's nucleotide cycle to specific trafficking and phosphoinositide outputs remain unknown.
• No PfARF1 GEF or GAP identified in the corpus
• In vivo PIP5K activation and its trafficking consequences not linked
• Structural basis of effector selection unresolved